Inactive Instrument

News Dyadic International, Inc. Other OTC

Equities

US26745T1016

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements	Apr. 08	AQ
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report	Apr. 04	AQ
Transcript : Dyadic International, Inc., 2023 Earnings Call, Mar 28, 2024	Mar. 28
Dyadic International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Dyadic Reports 2023 Full Year Results and Recent Company Progress	Mar. 28	AQ
Dyadic Says Patrick Lucy Named Board Chair; Joseph Hazelton Appointed COO	Mar. 28	MT
Dyadic Announces Change in Board and Management Leadership Roles	Mar. 28	GL
Dyadic International, Inc. Announces Management Changes	Mar. 28	CI
Trump Media (NASDAQ: DJT) Soars 24%: Opens at $71.93, Ignites Market Buzz Among DYAI, INBS, VTAK	Mar. 28	AQ
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK	Mar. 28	AQ
Dyadic International, Inc. (NASDAQ: DYAI) on "The Street Podcast" and Featured in Prestigious Science and Technology Journal - Tune In and Dive In!	Mar. 28	AQ
Dyadic to Attend Industry Events in April	Mar. 27	GL
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications	Mar. 26	GL
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California	Mar. 21	GL
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024	Mar. 14	GL
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP	Mar. 14	AQ
Dyadic International Inc. (NASDAQ: DYAI): A Value Play Gaining Investor Attention	Mar. 13	AQ
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization	Mar. 11	GL
Dyadic International, Inc. announced that it has received $6 million in funding	Mar. 07	CI
Biotech Breakthroughs: Dyadic International (NASDAQ: DYAI) Partners with Rabian BV to Combat Rabies	Mar. 04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Dyadic International, Inc. Other OTC

Equities

US26745T1016

Summary

Filters